Show simple item record

dc.contributor.authorMuth, C
dc.contributor.authorBeyer, M
dc.contributor.authorFortin, M
dc.contributor.authorRochon, J
dc.contributor.authorOswald, F
dc.contributor.authorValderas, JM
dc.contributor.authorHarder, S
dc.contributor.authorGlynn, LG
dc.contributor.authorPerera, R
dc.contributor.authorFreitag, M
dc.contributor.authorKaspar, R
dc.contributor.authorGensichen, J
dc.contributor.authorVan Den Akker, M
dc.date.accessioned2019-07-30T10:58:38Z
dc.date.issued2013-10-25
dc.description.abstractOlder patients, suffering from numerous diseases and taking multiple medications are the rule rather than the exception in primary care. A manifold of medical conditions are often associated with poor outcomes, and their multiple medications raise additional risks of polypharmacy. Such patients account for most healthcare expenditures. Effective approaches are needed to manage such complex patients in primary care. This paper describes the results of a scoping exercise, including a two-day workshop with 17 professionals from six countries, experienced in general practice and primary care research as well as epidemiology, clinical pharmacology, gerontology and methodology. This was followed by a consensus process investigating the challenges and core questions for multimorbidity research in primary care from a clinical perspective and presents examples of the best research practice. Current approaches in measuring and clustering multimorbidity inform policy-makers and researchers, but research is needed to provide support in clinical decision making. Multimorbidity presents a complexity of conditions leading to individual patient's needs and demanding complex processes in clinical decision making. The identification of patterns presupposes the development of strategies on how to manage multimorbidity and polypharmacy. Interventions have to be complex and multifaceted, and their evaluation poses numerous methodological challenges in study design, outcome measurement and analysis. Overall, it can be seen that complexity is a main underlying theme. Moreover, flexible study designs, outcome parameters and evaluation strategies are needed to account for this complexity. © 2014 Informa Healthcare.en_GB
dc.identifier.citationVol. 20 (2), pp. 139 - 147en_GB
dc.identifier.doi10.3109/13814788.2013.839651
dc.identifier.urihttp://hdl.handle.net/10871/38156
dc.language.isoenen_GB
dc.publisherTaylor & Francisen_GB
dc.subjectmultimorbidityen_GB
dc.subjectpolypharmacyen_GB
dc.subjectgeneral practiceen_GB
dc.subjectscoping exerciseen_GB
dc.subjectprocess evaluationen_GB
dc.titleMultimorbidity's research challenges and priorities from a clinical perspective: The case of 'Mr Curran'en_GB
dc.typeArticleen_GB
dc.date.available2019-07-30T10:58:38Z
dc.identifier.issn1381-4788
dc.descriptionThis is the final version. Available on open access from Taylor & Francis via the DOI in this recorden_GB
dc.identifier.journalEuropean Journal of General Practiceen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
pubs.euro-pubmed-idMED:24160250
dcterms.dateAccepted2013-08-13
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2013-10-25
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-07-30T10:56:16Z
refterms.versionFCDVoR
refterms.dateFOA2019-07-30T10:58:43Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record